Ganciclovir Oral, Intravenous and Mesalamine Controlled-Release Capsules
Determining the interaction of Ganciclovir Oral, Intravenous and Mesalamine Controlled-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ganciclovir
Brand name: Cytovene
Synonyms: Ganciclovir (injection), Ganciclovir (Systemic)
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ganciclovir Oral, Intravenous-Mesalamine Delayed Release Tablets
- Ganciclovir Oral, Intravenous-Mesalamine Long-Acting Capsules (Apriso)
- Ganciclovir Oral, Intravenous-Mesalamine Long-Acting Capsules (Delzicol)
- Ganciclovir Oral, Intravenous-Mesalamine Long-Acting Capsules (Pentasa)
- Ganciclovir Oral, Intravenous-Mesalamine rectal
- Ganciclovir Oral, Intravenous-Mesalamine Rectal Enema
- Mesalamine Controlled-Release Capsules-Ganciclovir Sodium
- Mesalamine Controlled-Release Capsules-Ganirelix
- Mesalamine Controlled-Release Capsules-Ganirelix Acetate
- Mesalamine Controlled-Release Capsules-Ganirelix Subcutaneous
- Mesalamine Controlled-Release Capsules-Ganite
- Mesalamine Controlled-Release Capsules-Gantrisin